세계의 올리고뉴클레오티드 합성 시장(제3판) : 올리고 길이별, 용도별, 카테고리별, 유형별, 제품별, 지역별 예측 - 경영진 컨설턴트 가이드와 인공지능(AI)의 영향(2025-2029년)

Oligonucleotide Synthesis Markets 3rd Edition. Forecasts by Oligo Length, Application, Category, Type, Product, and Region. With Executive and Consultant Guides. 2025 to 2029. Includes Impact of Artificial Intelligence

US $ 6,995 ￦ 9,690,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,538,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,387,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

합성 올리고뉴클레오타이드는 유전자 기술이 헬스케어, 식품 생산, 데이터 저장 등 다양한 분야에 적용되면서 폭발적인 성장세를 보이고 있습니다. 합성 DNA를 통해 조류와 같은 생물체는 자원을 거의 소비하지 않고도 식품과 의약품을 생산할 수 있도록 '맞춤 설계'할 수 있습니다. '올리고'는 이미 성숙시장과 신흥 시장에서 충분히 활약하고 있습니다. 그 가능성과 시장 성장은 무궁무진합니다. 우리의 분석에 따르면, 투자자들은 아직 이 기술의 범위와 거대한 시장 기회를 이해하지 못하고 있습니다. 작은 생명공학 기업이 DNA와 그 구성요소를 생산함으로써 거대한 다국적 기업이 될 수 있는 것입니다.

이 분야는 복잡하지만, 이 읽기 쉬운 보고서를 읽으면 모든 경영진이 기술과 기회에 대해 더 잘 이해할 수 있을 것입니다. 기술의 발전은 빠릅니다. 유전체학은 경계를 넘나들며 실험실에서 데스크톱으로 옮겨가고 있습니다.

세계의 올리고뉴클레오타이드 합성 시장에 대해 조사했으며, 시장 개요, 올리고 길이별/용도별/카테고리별/유형별/제품별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

• 올리고뉴클레오티드 합성이란 무엇인가
• 시장 정의
• 조사 방법
• 시점 : 헬스케어와 IVD 업계

제3장 올리고뉴클레오티드 합성

• 합성 기술
• 자동화
• 올리고뉴클레오티드의 유형
• PCR 프라이머
• PCR 어세이와 패널
• 시퀀싱
• DNA 마이크로어레이
• Fluorescence In Situ Hybridization (FISH)
• 안티센스 올리고뉴클레오티드
• 올리고뉴클레오티드의 기타 용도
• CRISPR와과 유전자 편집과의 관계

제4장 업계 개요

• 시장 참여 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품 및 시약 제조업체
  • 병리 공급업체
  • 독립계 임상 실험실
  • 공공 국립 및 지역 연구소
  • 병원 검사실
  • 임상 실험실
  • 감사기관
  • 인증기관

제5장 시장 요인

• 성장 촉진요인
• 성장 억제요인
• 향후 5년간

제6장 올리고뉴클레오티드 합성 최근 동향

제7장 주요 기업 개요

• Abbott Laboratories
• Agilent
• Ajinomoto Bio-Pharma
• Amyris
• Ansa BioTechnologies
• ATG : biosynthetics
• ATUM
• Azenta
• Bayer
• Beckman Coulter Diagnostics(Danaher)
• Becton, Dickinson and Company
• Biogen
• Biolytic Lab Performance
• Biomatik
• bioMerieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Biospring
• Bio-Synthesis
• Biotage
• Blue Heron Biotechnology(Eurofins Genomic)
• Camena Bioscience
• Cepheid(Danaher)
• Chemgenes
• Codexis
• Cytena
• Diasorin S.p.A.
• DNA Script
• Enzo Biochem
• Eurofins Scientific
• Eurogentec(Kaneka)
• Evonetix
• FASMAC
• GE Healthcare
• Genomatica
• Genscript Biotech
• Glycogene Inc.
• Hologic
• Hongene Biotech
• Innovassynth
• Integrated DNA Technologies(Danaher)
• Ionis Pharmaceuticals
• J&J Innovative Medicine
• Kern Systems
• LGC Biosearch Technologies
• Macrogen
• Maravai LifeSciences Holdings
• Merck & Co., Inc
• Microsynth
• Millipore Sigma
• Molecular Assemblies
• New England Biolabs, Inc.
• Nippon Shinyaku
• Nitto Denko(Avecia)
• Nuclera
• Oligo Factory
• Panagene
• Primerdesign(Novacyt)
• Qiagen
• Revvity
• Roche Diagnostics
• Seegene
• Siemens Healthineers
• Synthego
• TAG Copenhagen A/S
• Thermo Fisher Scientific
• Twist Bioscience

제8장 세계의 올리고뉴클레오티드 합성 시장 개요

• 국가별 세계 시장 개요
• 길이별 세계 시장 규모 - 개요
• 용도별 세계 시장 규모 - 개요
• 제품별 세계 시장 규모 - 개요
• 카테고리별 세계 시장 규모 - 개요
• 유형별 세계 시장 규모 - 개요

제9장 길이별 세계 시장

• 20mer 미만
• 21-50mer
• 51-100mer
• 100mer

제10장 용도별 세계 시장

• 연구
• 진단
• 치료
• 데이터

제11장 제품별 세계 시장

• 올리고뉴클레오티드
• 기기
• 뉴클레오티드
• 기타 시약

제12장 카테고리별 세계 시장

• 프라이머
• 프로브
• DNA
• RNA
• 기타 핵산

제13장 유형별 세계 시장

• 표준 올리고뉴클레오티드
• 커스텀 올리고뉴클레오티드

제14장 부록

LSH

영문 목차

영문목차

OVERVIEW:

Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, data storage. With Synthetic DNA, organisms, like algae, are "custom designed" to produce food and medicine while consuming few resources. "Oligos" are already hard at work in both mature and emerging market segments. The possibilities, and market growth are unlimited. Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity. Small biotechs could become huge multinationals, all based on producing DNA and its building blocks. Learn all about it and see our forecasts in this comprehensive report.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genomics itself crosses the chasm.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants
• 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

• 2.1. What is Oligonucleotide Synthesis?
  • 2.1.1. The Enzyme Race
  • 2.1.2. Data Storage - The Elephant in the Room
• 2.2. Market Definition
  • 2.2.1. Market Size
  • 2.2.2. Currency
  • 2.2.3. Years
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Oligonucleotide Synthesis

• 3.1. Synthesis Technology
• 3.2. Automation
• 3.3. Types of Oligonucleotides
• 3.4. PCR Primers
• 3.5. PCR Assays and Panels
• 3.6. Sequencing
• 3.7. DNA Microarrays
• 3.8. Fluorescence In Situ Hybridization (FISH)
• 3.9. Antisense Oligonucleotides
• 3.10. Other Uses of Oligonucleotides
• 3.11. Relationship to CRISPR and Gene Editing

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Instrumentation Supplier
  • 4.1.4. Chemical/Reagent Supplier
  • 4.1.5. Pathology Supplier
  • 4.1.6. Independent Clinical Laboratory
  • 4.1.7. Public National/regional Laboratory
  • 4.1.8. Hospital Laboratory
  • 4.1.9. Physicians Office Lab (POLS)
  • 4.1.10. Audit Body
  • 4.1.11. Certification Body

5. Market Factors

• 5.1. Factors Driving Growth
  • 5.1.1. The Role of Diagnostics and the Covid Effect
  • 5.1.2. The RNA Based Vaccine
  • 5.1.3. Genomic Blizzard
  • 5.1.4. Antisense Revival
  • 5.1.5. New Applications
• 5.2. Factors Limiting Growth
  • 5.2.1. Declining Price
  • 5.2.2. Technology Lag
  • 5.2.3. COVID Realignment
• 5.3. The Next Five Years

6. Oligonucleotide Synthesis Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. Ono Pharmaceutical to acquire antisense oligonucleotide treatment
• 6.3. Codexis Enables Manufacturing of RNAi Therapeutics
• 6.4. Codexis Successfully Uses Enzymatic Synthesis
• 6.5. Oligo Factory Achieves GMP Compliance
• 6.6. Oligonucleotide Synthesis Scaled Up
• 6.7. Antisense Oligonucleotide Lowers Tau Tangles
• 6.8. Ansa Biotechnologies Synthesizes Longest Oligo at 1005 Bases
• 6.9. Agilent will double oligonucleotide capacity
• 6.10. RNA Synthesis Technology Commercialized by EnPlusOne
• 6.11. Quick and Automated Printing of Custom Oligos
• 6.12. WuXi STA Opens Large-Scale Oligo Manufacturing Facility
• 6.13. Secarna Pharmaceuticals' and Evotec Achieve Programme Designation
• 6.14. Aligos Discontinues Development of its Antisense Oligonucleotide
• 6.15. Seegene Obtains CE Mark for Oligo Based SARS-CoV-2 Assay
• 6.16. Biofidelity to Launch Mutation Detection Assay
• 6.17. Oligonucleotide Therapeutics Society Holds Meeting
• 6.18. New Oligonucleotide Synthesis Chemistry
• 6.19. Antisense Oligonucleotides Cross Rodents' Blood-Brain Barrier
• 6.20. New Rapid Multiplexed PCR Assay Uses Oligo Probes
• 6.21. MIT Devises Oligo 'File System' for DNA Data Storage
• 6.22. Nuclera Acquires E Ink Digital Microfluidics Business
• 6.23. Twist Bioscience Hits Milestone for DNA Data Storage
• 6.24. Twist Bioscience, Vivlion Partner on RNA Libraries for CRISPR
• 6.25. DNA Script Launching Benchtop Synthesizer for 'DNA on Demand'
• 6.26. RNA Disease Dx to Develop PoC Covid Test
• 6.27. Evonetix and Analog Devices Develop GEN3 DNA Synthesis Platform
• 6.28. ATDBio Receives Grant for Cancer Diagnosis Project
• 6.29. Twist Bioscience Announces Therapeutic Ab
• 6.30. Drugmakers boost oligo capacity amid Covid-19
• 6.31. Aligos Therapeutics in Study of Oligo Candidate
• 6.32. DNA Script Raises $89M for SYNTAX Launch
• 6.33. Codexis & Molecular Assemblies Partner for DNA Synthesis
• 6.34. NuProbe Licenses Oligo Technology from Rice
• 6.35. Genome editing with Cas9-oligo conjugates
• 6.36. OliX Pharma and AM Chemicals Partner for RNA Synthesis Support
• 6.37. Twist Bio To End Trade Secrets Suit
• 6.38. DNA Script, partners get grant for data storage
• 6.39. Xi's STA unit opens oligonucleotide plant

7. Profiles of Key Companies

• 7.1. Abbott Laboratories
• 7.2. Agilent
• 7.3. Ajinomoto Bio-Pharma
• 7.4. Amyris
• 7.5. Ansa BioTechnologies
• 7.6. ATG:biosynthetics
• 7.7. ATUM
• 7.8. Azenta
• 7.9. Bayer
• 7.10. Beckman Coulter Diagnostics (Danaher)
• 7.11. Becton, Dickinson and Company
• 7.12. Biogen
• 7.13. Biolytic Lab Performance
• 7.14. Biomatik
• 7.15. bioMerieux Diagnostics
• 7.16. Bioneer Corporation
• 7.17. Bio-Rad Laboratories, Inc.
• 7.18. Biospring
• 7.19. Bio-Synthesis
• 7.20. Biotage
• 7.21. Blue Heron Biotechnology (Eurofins Genomic)
• 7.22. Camena Bioscience
• 7.23. Cepheid (Danaher)
• 7.24. Chemgenes
• 7.25. Codexis
• 7.26. Cytena
• 7.27. Diasorin S.p.A.
• 7.28. DNA Script
• 7.29. Enzo Biochem
• 7.30. Eurofins Scientific
• 7.31. Eurogentec (Kaneka)
• 7.32. Evonetix
• 7.33. FASMAC
• 7.34. GE Healthcare
• 7.35. Genomatica
• 7.36. Genscript Biotech
• 7.37. Glycogene Inc.
• 7.38. Hologic
• 7.39. Hongene Biotech
• 7.40. Innovassynth
• 7.41. Integrated DNA Technologies (Danaher)
• 7.42. Ionis Pharmaceuticals
• 7.43. J&J Innovative Medicine
• 7.44. Kern Systems
• 7.45. LGC Biosearch Technologies
• 7.46. Macrogen
• 7.47. Maravai LifeSciences Holdings
• 7.48. Merck & Co., Inc
• 7.49. Microsynth
• 7.50. Millipore Sigma
• 7.51. Molecular Assemblies
• 7.52. New England Biolabs, Inc.
• 7.53. Nippon Shinyaku
• 7.54. Nitto Denko (Avecia)
• 7.55. Nuclera
• 7.56. Oligo Factory
• 7.57. Panagene
• 7.58. Primerdesign (Novacyt)
• 7.59. Qiagen
• 7.60. Revvity
• 7.61. Roche Diagnostics
• 7.62. Seegene
• 7.63. Siemens Healthineers
• 7.64. Synthego
• 7.65. TAG Copenhagen A/S
• 7.66. Thermo Fisher Scientific
• 7.67. Twist Bioscience

8. Oligonucleotide Synthesis Global Market Overview

• 8.1. Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market Size by Length - Overview
  • 8.2.1. Table - Global Market by Length
  • 8.2.2. Chart - Global Market by Length - Base/Final Year Comparison
  • 8.2.3. Chart - Global Market by Length - Base Year
  • 8.2.4. Chart - Global Market by Length - Final Year
  • 8.2.5. Chart - Global Market by Length - Share by Year
  • 8.2.6. Chart - Global Market by Length - Segment Growth
• 8.3. Global Market Size by Application - Overview
  • 8.3.1. Table - Global Market by Application
  • 8.3.2. Chart - Global Market by Application - Base/Final Year Comparison
  • 8.3.3. Chart - Global Market by Application - Base Year
  • 8.3.4. Chart - Global Market by Application - Final Year
  • 8.3.5. Chart - Global Market by Application - Share by Year
  • 8.3.6. Chart - Global Market by Application - Segment Growth
• 8.4. Global Market Size by Product - Overview
  • 8.4.1. Table - Global Market by Product
  • 8.4.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 8.4.3. Chart - Global Market by Product - Base Year
  • 8.4.4. Chart - Global Market by Product - Final Year
  • 8.4.5. Chart - Global Market by Product - Share by Year
  • 8.4.6. Chart - Global Market by Product - Segment Growth
• 8.5. Global Market Size by Category - Overview
  • 8.5.1. Table - Global Market by Category
  • 8.5.2. Chart - Global Market by Category - Base/Final Year Comparison
  • 8.5.3. Chart - Global Market by Category - Base Year
  • 8.5.4. Chart - Global Market by Category - Final Year
  • 8.5.5. Chart - Global Market by Category - Share by Year
  • 8.5.6. Chart - Global Market by Category - Segment Growth
• 8.6. Global Market Size by Type - Overview
  • 8.6.1. Table - Global Market by Type
  • 8.6.2. Chart - Global Market by Type - Base/Final Year Comparison
  • 8.6.3. Chart - Global Market by Type - Base Year
  • 8.6.4. Chart - Global Market by Type - Final Year
  • 8.6.5. Chart - Global Market by Type - Share by Year
  • 8.6.6. Chart - Global Market by Type - Segment Growth

9. Global Market by Length

• 9.1. less than 20 mer Market
  • 9.1.1. Table - less than 20 mer Market by Country
  • 9.1.2. Chart - less than 20 mer Market Segment Growth
• 9.2 21-50 mer Market
  • 9.2.1. Table - 21-50 mer Market by Country
  • 9.2.2. Chart - 21-50 mer Market Segment Growth
• 9.3. 51-100 mer Market
  • 9.3.1. Table - 51-100 mer Market by Country
  • 9.3.2. Chart - 51-100 mer Market Segment Growth
• 9.4. greater than 100 mer Market
  • 9.4.1. Table - greater than 100 mer Market by Country
  • 9.4.2. Chart - greater than 100 mer Market Segment Growth

10. Global Market by Application

• 10.1. Research Market
  • 10.1.1. Table - Research Market by Country
  • 10.1.2. Chart - Research Market Segment Growth
• 10.2. Diagnostics Market
  • 10.2.1. Table - Diagnostics Market by Country
  • 10.2.2. Chart - Diagnostics Market Segment Growth
• 10.3. Therapeutics Market
  • 10.3.1. Table - Therapeutics Market by Country
  • 10.3.2. Chart - Therapeutics Market Segment Growth
• 10.4. Data Market
  • 10.4.1. Table - Data Market by Country
  • 10.4.2. Chart - Data Market Segment Growth

11. Global Market by Product

• 11.1. Oligonucleotides Market
  • 11.1.1. Table - Oligonucleotides Market by Country
  • 11.1.2. Chart - Oligonucleotides Market Segment Growth
• 11.2. Instruments Market
  • 11.2.1. Table - Instruments Market by Country
  • 11.2.2. Chart - Instruments Market Segment Growth
• 11.3. Nucleosides Market
  • 11.3.1. Table - Nucleosides Market by Country
  • 11.3.2. Chart - Nucleosides Market Segment Growth
• 11.4. Other Reagents Market
  • 11.4.1. Table - Other Reagents Market by Country
  • 11.4.2. Chart - Other Reagents Market Segment Growth

12. Global Market by Category

• 12.1. Primer Market
  • 12.1.1. Table - Primer Market by Country
  • 12.1.2. Chart - Primer Market Segment Growth
• 12.2. Probe Market
  • 12.2.1. Table - Probe Market by Country
  • 12.2.2. Chart - Probe Market Segment Growth
• 12.3. DNA Market
  • 12.3.1. Table - DNA Market by Country
  • 12.3.2. Chart - DNA Market Segment Growth
• 12.4. RNA Market
  • 12.4.1. Table - RNA Market by Country
  • 12.4.2. Chart - RNA Market Segment Growth
• 12.5. Other Nucleic Acid Market
  • 12.5.1. Table - Other Nucleic Acid Market by Country
  • 12.5.2. Chart - Other Nucleic Acid Market Segment Growth

13. Global Market by Type

• 13.1. Standard Oligonucleotides Market
  • 13.1.1. Table - Standard Oligonucleotides Market by Country
  • 13.1.2. Chart - Standard Oligonucleotides Market Segment Growth
• 13.2. Custom Oligonucleotides Market
  • 13.2.1. Table - Custom Oligonucleotides Market by Country
  • 13.2.2. Chart - Custom Oligonucleotides Market Segment Growth

14. Appendices

• 14.1. Typical Oligo Synthesis Price Lists
• 14.2. Medicare Clinical Lab Fee Schedule
• 14.3. Drug Approvals by Molecule Type - A Seven Year View
• 14.4. Growth of Approved IVD Test Menu
• 14.5. Growth of Approved Average IVD Test Fee
• 14.6. Share of Pharma R&D by Country

관련자료